Skip to content

Clinical trials

Phase 3 Purpura, Thrombocytopenic, Idiopathic trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Purpura, Thrombocytopenic, Idiopathic Phase: Phase 3 Country / region: Spain Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20091
20121
20142
20151
20161
20191
20204
20211
20221
20232
20241
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting5
Active, not recruiting3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
argenx4
Novartis Pharmaceuticals3
Amgen2
GlaxoSmithKline2
Rigel Pharmaceuticals2
Takeda2
UCB Biopharma SRL2
Biotest1
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla1
Kedrion S.p.A.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Purpura, Thrombocytopenic, Idiopathic22
Thrombocytopenia5
Purpura4
Autoimmune Diseases3
Blood Platelet Disorders3
Hematologic Diseases3
Hemorrhagic Disorders3
Cytopenia2
Hemorrhage2
Immune System Diseases2

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.